Our Lens Partner
At Solasta we are passionate about your quality of life after your treatment
Not all cataract surgery is the same.
Choosing the right lens is one of the most important parts of cataract surgery. Our surgeons have the right experience and expertise to select the right lens to deliver the best visual outcome and improve patient comfort.
At Solasta Healthcare, we offer a unique range of intra-ocular lens (IOL) implants designed to provide a full range of distance and vision with minimal side effects. This means we can achieve the very best visual outcome and ensure a perfect fit for every patient.
Alcon is the largest eye care device company in the world and the global leader in quality and leading the way with real-world clinical data.
Alcon has a large choice of dioptres for all your visual requirements
Alcon® has been helping people see better since 1947 and Alcon’s intraocular lenses (IOL) for cataract surgery are the most widely implanted lenses in the world. We use Alcon’s technology, lenses and consumables - a comprehensive portfolio of superb products.
Low PCO and Nd: YAG Rates - Reduction in secondary treatments
Excellent Quality of Vision - Proven long-lasting visual outcomes
Trusted by Surgeons Over 125 million implants worldwide
For any further information, our team will talk you through it in your consultations.
Since 1994, over 100 million people have had their sight restored and improved with an Alcon IOL.
Solasta Healthcare use Alcon’s UltraSert® for their cataract patients. This is Alcon’s most trusted and most widely implanted AcrySof® brand lens that is preloaded into a delivery system for your surgeon to use.
Preloading means there is a lower risk of damage to the lens through handling and manual loading and also the added confidence of absolute sterility as the lens is never exposed to the air.
This makes the procedure more efficient and smoother for your surgical team, helping to make your surgery straightforward and even a little shorter.
Ranked #1 for global sales in surgical IOLs
125+ million AcrySof® IOLs implanted worldwide
25+ years proven effectiveness
RCOphth National Ophthalmology Database Audit Feasibility Study of Post-cataract Posterior Capsule Opacification https://www.nodaudit.org.uk/u/docs/20/rijbxkcubs/RCOphth%20NOD%20PCO%20Report%202021.pdf Accessed 14 July 2021
The AcrySof platform range of lenses from Alcon have been specifically designed to improve visual clarity and image quality after cataract surgery.
Following a recent audit of the National Ophthalmology Database, The Royal College of Ophthalmologists published a report titled ‘Feasibility study of Post-Cataract Capsule Opacification 2021”.
This was the largest ever audit of cataract procedures; more than 600k procedures carried out by over 2500 surgeons in 58 NHS centres were reviewed.
The data considered Posterior Capsular Opacification (PCO) to identify factors that influence variance in rates.
The data suggests a strong association between the intraocular lens (IOL) used and PCO rates.
Finally, of all available cataract replacement lenses available today, AcrySof’s unique design and lens material have been proven to have the lowest rates of post-operative complications.
Book a consultation and let’s see if now’s the right time for cataract surgery
Patient Reviews
